[DFI] Announcement of Shareholders' Meeting Resolution to Lift Non-Compete Restrictions for Directors and Representatives
DFI Inc. announced that its shareholders' meeting on May 27, 2026, approved the lifting of non-compete restrictions for its directors and their representatives, including those from Qisda Corporation.
📋 Article Processing Timeline
- 📰 Published: May 27, 2026 at 09:00
- 🔍 Collected: May 28, 2026 at 08:00 (23h 0m after Published)
- 🤖 AI Analyzed: May 31, 2026 at 18:59 (82h 59m after Collected)
1. Date of Shareholders' Meeting: 2026/05/27
2. Names and titles of directors permitted to engage in competitive activities: (List includes Qisda Corporation and its representatives Chen Chi-hung, Tseng Wen-hsing, Tien Chih-ying, and independent directors).
3. Items of permitted competitive activities: (Detailed list of concurrent positions in various Qisda-affiliated companies).
4. Duration of permission: During the term of office as a director or representative of the company.
5. Resolution status: Approved by a majority of votes represented by shareholders holding at least two-thirds of the total issued shares.
6. Competitive activities involving Mainland China: Chen Chi-hung and Tseng Wen-hsing.
7. Mainland China entities and positions: Positions in Nanjing BenQ Hospital, Suzhou BenQ Hospital, etc.
8. Addresses of Mainland China entities: Locations in Nanjing and Suzhou.
9. Business scope in Mainland China: Medical services, management consulting, and software R&D.
10. Impact on financial operations: None.
11. Investment amount and shareholding ratio: None.
12. Other matters: None.
2. Names and titles of directors permitted to engage in competitive activities: (List includes Qisda Corporation and its representatives Chen Chi-hung, Tseng Wen-hsing, Tien Chih-ying, and independent directors).
3. Items of permitted competitive activities: (Detailed list of concurrent positions in various Qisda-affiliated companies).
4. Duration of permission: During the term of office as a director or representative of the company.
5. Resolution status: Approved by a majority of votes represented by shareholders holding at least two-thirds of the total issued shares.
6. Competitive activities involving Mainland China: Chen Chi-hung and Tseng Wen-hsing.
7. Mainland China entities and positions: Positions in Nanjing BenQ Hospital, Suzhou BenQ Hospital, etc.
8. Addresses of Mainland China entities: Locations in Nanjing and Suzhou.
9. Business scope in Mainland China: Medical services, management consulting, and software R&D.
10. Impact on financial operations: None.
11. Investment amount and shareholding ratio: None.
12. Other matters: None.
FAQ
What is the lifting of non-compete restrictions?
It is a corporate governance procedure where shareholders approve directors to hold concurrent positions in other companies that might compete with the firm.